RESMED INC — Director's Dealing 2019

Nov 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2019-11-21

Reporting Person: Drexler Karen (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-21	ResMed Common Stock	A	863	—	Acquired	6387	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-21	ResMed Common Stock Options	$146.34	A	3889	Acquired	2026-11-21	ResMed Common Stock (3889)	Direct

Footnotes

F1: Shares awarded are restricted stock units. The RSUs vest on the earlier of November 11, 2020, or the annual shareholders meeting in the year following the grant date.

F2: Options vest in full (i) on the first Nov. 11 following the grant date or (ii) the first annual shareholders meeting following grant date.